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Abstract
 
Natural killer T (NKT) cells are a highly conserved subset of T cells that have been shown to
play a critical role in suppressing T helper cell type 1–mediated autoimmune diseases and graft
versus host disease in an interleukin (IL)-4–dependent manner. Thus, it is important to under-
stand how the development of IL-4– versus interferon (IFN)-
 
g
 
–producing NKT cells is regu-
lated. Here, we show that NKT cells from adult blood and those from cord blood undergo
massive expansion in cell numbers (500–70,000-fold) during a 4-wk culture with IL-2, IL-7,
phytohemagglutinin, anti-CD3, and anti-CD28 mAbs. Unlike adult NKT cells that preferen-
tially produce both IL-4 and IFN-
 
g
 
, neonatal NKT cells preferentially produce IL-4 after poly-
clonal activation. Addition of type 2 dendritic cells (DC2) enhances the development of neo-
natal NKT cells into IL-4
 
1
 
IFN-
 
g
 
2
 
 NKT2 cells, whereas addition of type 1 dendritic cells
(DC1) induces polarization towards IL-4
 
2
 
IFN-
 
g
 
1
 
 NKT1 cells. Adult NKT cells display lim-
ited plasticity for polarization induced by DC1 or DC2. Thus, newly generated NKT cells may
possess the potent ability to develop into IL-4
 
1
 
IFN-
 
g
 
2
 
 NKT2 cells in response to appropriate
stimuli and may thereafter acquire the tendency to produce both IL-4 and IFN-
 
g
 
.
Key words: cord blood • interleukin 4 • interferon 
 
g
 
 • autoimmune diseases • graft versus host 
disease
 
Introduction
 
NKT cells are a conserved subset of T cells that express a
highly limited TCR repertoire, composed of an invariant
TCR 
 
a
 
 chain (V
 
a
 
24-J
 
a
 
Q in humans) and a biased set of
TCR 
 
b
 
 chains (predominantly V
 
b
 
11 in humans) (1). These
TCRs recognize a nonpolymorphic, MHC class I–like
molecule, CD1d, which presents glycolipids (2). NKT cells
have a conspicuous ability to rapidly produce large amounts
of IL-4 and IFN-
 
g
 
 upon TCR triggering (1), suggesting a
regulatory function at the early stage of immune responses.
Development of various autoimmune diseases in mice (3,
4) and humans (5, 6) was found to be associated with a de-
crease in the number of NKT cells. NKT cells have been
shown to prevent diabetes in nonobese diabetic mice (7)
and graft versus host disease (GVHD) after bone marrow
transplantation (8) in an IL-4–dependent manner. These
findings indicate that NKT cells are an important regulatory
cell type that prevents a variety of deleterious immune re-
sponses. Thus, it is important to understand how the devel-
 
opment of IL-4– versus IFN-
 
g
 
–producing NKT cells is
regulated. Furthermore, obtaining a large number of IL-4–
producing NKT cells may be instrumental in controlling
certain autoimmune diseases and GVHD. To this end, two
questions need to be addressed. First, because the frequency
of NKT cells in human blood is extremely low (9–11), how
can we expand NKT cell numbers? Second, because most
NKT cells produce both IL-4 and IFN-
 
g
 
, how can we pro-
mote NKT cells to produce only IL-4 but not IFN-
 
g
 
?
In humans, small numbers of NKT cells exist in umbili-
cal cord blood and adult blood (9–11). Recent studies have
shown that not only NKT cells in adult blood (adult NKT
cells) but also those in cord blood (neonatal NKT cells)
have an activated/memory phenotype (10, 11), suggesting
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that human NKT cells are stimulated even before birth,
probably by endogenous ligands. However, in contrast to
adult NKT cells, neonatal NKT cells do not produce IL-4
or IFN-
 
g
 
 upon primary stimulation (11). This suggests that
neonatal NKT cells are functionally immature at birth and
need to be primed to become fully functional. Thus, the
nature of initial stimuli may strongly influence the direction
of neonatal NKT cell differentiation, i.e., toward IL-
4
 
2
 
IFN-
 
g
 
1
 
 
 
NKT1 versus IL-4
 
1
 
IFN-
 
g
 
2
 
 
 
NKT2 cells.
Recent studies have shown that distinct types of den-
dritic cells (DCs) are capable of directing Th differentiation
toward a Th1 or Th2 type (12). In humans, monocyte-
derived DCs (designated DC1) produce a large amount of
IL-12 after stimulation with maturation-inducing factors
such as CD40 ligand (L) and induce Th1 differentiation of
naive CD4
 
1
 
 T cells (13). In contrast, type 2 dendritic cells
(DC2), which develop from CD4
 
1
 
CD3
 
2
 
CD11c
 
2
 
 plasma-
cytoid cells in the presence of IL-3 and CD40L (13) or
TNF-
 
a 
 
(14), do not produce a significant amount of IL-12
and preferentially induce Th2 differentiation. Recent stud-
ies have shown that CD1d-expressing DCs stimulate
mouse (2) and human (15) NKT cells. Thus, the type of
DCs may also influence NKT cell differentiation into
NKT1 or NKT2 cells.
Here, we studied how to obtain a large number of IL-
4–producing NKT2 cells in vitro. To this end, we cultured
NKT cells from cord blood or adult blood with anti-CD3
and anti-CD28 mAbs, DC1, or DC2 in the presence of
IL-2, IL-7, and PHA. We show that neonatal NKT cells
undergo massive proliferation and strong polarization to-
ward NKT2 cells during 4-wk culture with IL-2, IL-7,
PHA, anti-CD3, and anti-CD28 mAbs. Addition of DC2
enhances the differentiation of neonatal NKT cells into
NKT2 cells.
 
Materials and Methods
 
Isolation of NKT Cells from Cord Blood or Adult Blood.
 
Cord
blood and buffy coat from healthy donors were purchased from
Advanced Bioscience Technologies and Stanford Blood Center,
respectively. B cells and monocytes were depleted from mononu-
clear cells using anti-CD19 and anti-CD14 mAbs and magnetic
beads coated with goat anti–mouse IgG (Dynabeads M-450). The
cells were frozen until needed. They were stained with FITC-
conjugated anti-V
 
a
 
24 (C15) and PE-conjugated anti-V
 
b
 
11
mAbs (C21; Immunotech). V
 
a
 
24
 
1
 
V
 
b
 
11
 
2
 
 conventional T cells
and V
 
a
 
24
 
1
 
V
 
b
 
11
 
1
 
 NKT cells were purified by cell sorting.
 
Generation of DC1 and DC2.
 
Monocytes and CD4
 
1
 
CD11c
 
2
 
lin
 
2
 
 DC2 precursors were isolated from human periph-
eral blood as described previously (16). The cells were cultured in
RPMI 1640 (BioWhittaker) supplemented with 10% FCS (Bio-
Whittaker), 2 mM 
 
L
 
-glutamine, 10 mM Hepes, 1 mM sodium
pyruvate, 55 
 
m
 
M 2-mercaptoethanol, penicillin G, and strepto-
mycin (all from Life Technologies). Monocytes were cultured in
the presence of 50 ng/ml GM-CSF (Schering-Plough) and 200
U/ml IL-4 (Schering-Plough) for 6 d. The resulting immature
DCs were washed and cultured for 2 d with human CD40L–
transfected L cells (16) (irradiated at 5,500 rads), to obtain mature
DC1. CD4
 
1
 
CD11c
 
2
 
lin
 
2
 
 DC2 precursors were cultured with 10
 
ng/ml IL-3 (R&D Systems) and irradiated CD40L-transfected L
cells for 6 d to obtain mature DC2.
 
Sequencing of TCR V
 
a
 
24 mRNA.
 
cDNAs of TCR-
 
a
 
 tran-
scripts were amplified by PCR. The primers were V
 
a
 
24 sense,
5
 
9
 
-GATATACAGCAACTCTGGATGCA-3
 
9
 
 and C
 
a
 
 antisense,
5
 
9
 
-TGAAGTCCATAGACCTCATGTC-3
 
9
 
. PCR products
were subcloned using a TA Cloning
 
®
 
 Kit (Invitrogen), and the
nucleotide sequences were determined by automated sequencing
using an Applied Biosystems 373 sequencer.
 
In Vitro Expansion of NKT Cells and Coculture with DCs.
 
V
 
a
 
24
 
1
 
V
 
b
 
11
 
1
 
 NKT cells were stimulated with allogeneic DC1,
allogeneic DC2, or plate-bound anti-CD3 mAb SPV-T3b (10
 
m
 
g/ml; reference 16) and 1 
 
m
 
g/ml soluble anti-CD28 mAb
L293.1 (Becton Dickinson) in Yssel’s medium (Irvine Scientific)
containing 10% FCS, 100 U/ml IL-2 (Schering-Plough), 50 ng/
ml IL-7 (R&D Systems), and 0.5 
 
m
 
g/ml PHA (Wellcome Diag-
nostics). NKT cells from cord blood were cultured in Terasaki
plates (300–1,500 T cells per well depending on available cell
numbers), and those from adult blood were cultured in 96-well
round-bottomed culture plates (1,500–16,000 T cells per well).
DC1 and DC2 were irradiated (3,000 rads) and cultured with
NKT cells at a 1:2 DCs/T cells. The proliferating cells were sup-
plemented with medium containing IL-2 and IL-7 but not PHA.
After 14 d of stimulation, the cells were restimulated for another
14 d under the same condition as the first stimulation. The re-
sulting cells were used for cytokine assays. The purity of
V
 
a
 
24
 
1
 
V
 
b
 
11
 
1
 
 cells was 
 
.
 
95% at the time of restimulation for cy-
tokine assays.
 
Analysis of Cytokine Production by ELISA or Flow Cytometry.
 
10
 
6
 
 NKT cells per milliliter were restimulated with plate-bound
anti-CD3 and 1 
 
m
 
g/ml soluble anti-CD28 mAbs for 24 h. IFN-
 
g
 
and IL-4 in supernatants were measured with a Quantikine
ELISA kit (R&D Systems). Intracellular cytokines produced by
NKT cells were analyzed by flow cytometry as described (13).
 
Results
 
Both Adult and Neonatal NKT Cells Undergo Massive Ex-
pansion in Cultures with IL-2, IL-7, PHA, Anti-CD3, and
Anti-CD28 mAbs.
 
NKT cells were isolated from cord
blood and adult blood by cell sorting, based on the double
expression of V
 
a
 
24 and V
 
b
 
11 (17). The frequency of
V
 
a
 
24
 
1
 
V
 
b
 
11
 
1
 
 
 
NKT cells in cord blood was 0.031 
 
6
 
0.023% (SD) of total lymphocytes (range 0.001–0.083%,
 
n
 
 
 
5
 
 11), which tended to be lower than the frequency in
adult blood (0.094 
 
6
 
 0.129% of total lymphocytes, range
0.007–0.540%, 
 
n
 
 
 
5
 
 16). Previous studies showed that IL-2
and IL-7 are important for NKT cell proliferation (18, 19).
Therefore, 1,500–16,000 adult NKT cells or 300–1,500
neonatal NKT cells were cultured with IL-2, IL-7, PHA,
anti-CD3, and anti-CD28 mAbs. After 2 wk of culture,
between 0.08 and 6.2 
 
3
 
 10
 
6
 
 NKT cells were generated,
representing a 30–7,600-fold expansion (Table I). After
two more weeks of culture in the same condition, 1.2–
27 
 
3
 
 10
 
6
 
 NKT cells were obtained, representing a total
500–70,000-fold expansion. As compared with the expan-
sion during the first 2 wk (30–7,600-fold), the expansion
during the second 2 wk was modest (2–16-fold), possibly
due to clonal exhaustion caused by continuous stimulation.
These results indicate that although only small numbers of
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NKT cells are isolated from adult and cord blood, NKT
cells can be efficiently expanded in cultures.
More than 95% of cultured NKT cells expressed
V
 
a
 
24
 
1
 
V
 
b
 
11
 
1
 
 cells after the 4 wk of culture by FACS®
analyses (data not shown). In addition, sequence analyses of
TCR a chains of these cultured cells showed the invariant
Va24-JaQ TCR without N sequences, which is identical
to that reported for NKT cells (reference 20 and data not
shown). In contrast, cDNA sequences of TCR a chains of
Va241Vb112 T cells were polyclonal at the V–J junctions
and the J regions (data not shown). These data indicate that
the expanded cells after 4 wk of culture are NKT cells but
not contaminating cells.
Neonatal but Not Adult NKT Cells Preferentially Become
IL-41IFN-g2 NKT2 Cells after Polyclonal Stimulation. To
determine the potential of cytokine production by the ex-
panded NKT cells, the cells were restimulated with anti-
CD3 and anti-CD28 mAbs for either 5 (intracellular cyto-
kine staining) or 24 h (cytokine analyses by ELISA). Adult
NKT cells produced considerable amounts of both IL-4
(268–885 pg/ml) and IFN-g (2,914–3,366 pg/ml; Table
II). Intracellular cytokine staining showed that the adult
NKT cells mainly differentiated into IL-42IFN-g1 NKT1
cells (23%) and IL-41IFN-g1 NKT0 (16%; Fig. 1). Only
8% of the cells differentiated into IL-41IFN-g2 NTT2 cells.
This confirms the previous finding that NKT cells produce
both IL-4 and IFN-g upon activation through TCRs (1).
Interestingly, neonatal NKT cells produced two to six
times more IL-4 (548–5,559 pg/ml) but two to four times
less IFN-g (650–1,889 pg/ml) than adult NKT cells (Table
II). These differences are reflected in higher IL-4/IFN-g
ratios from neonatal NKT cells than those from adult NKT
cells (Table II). Intracellular cytokine staining showed that
the predominant population of neonatal NKT cells became
IL-41IFN-g2 NKT2 cells (31%; Fig. 1). Only 5 and 4% of
the NKT cells differentiated into IL-41IFN-g1 NKT0 and
IL-42IFN-g1 NKT1 cells, respectively. These data indi-
cate that neonatal NKT cells and adult NKT cells display
strikingly different patterns of cytokine production; neona-
tal and adult NKT cells preferentially develop into IL-
41IFN-g2 NKT2 cells and IL-41IFN-g1 NKT0 cells, re-
spectively, in response to TCR engagement.
DC2 Promote Neonatal NKT Cells To Become IL-41IFN-g2
NKT2 Cells. Because neonatal NKT cells preferen-
tially develop into IL-41IFN-g2 NKT2 cells after poly-
clonal stimulation, we asked whether addition of Th2-
inducing DCs could further promote neonatal NKT cell
development into the NKT2 type. Our previous study
showed that while CD40L-activated monocyte-derived
Table I. Adult and Neonatal NKT Cell Expansion after Cultures with Anti-CD3 and Anti-CD28 mAbs
Day 0 Day 14 Day 28
Cell number Cell number Fold increase Cell number Fold increase
Adult NKT Exp. 1 16 2,200 140 7,700 480
Exp. 2 16 500 31 NA NA
Exp. 3 1.5 78 52 1,210 810
Neonatal NKT Exp. 1 1.5 6,200 4,100 NA NA
Exp. 2 0.4 3,030 7,600 27,000 67,500
Exp. 3 0.3 920 3,100 1,910  6,400
Va241Vb111 NKT cells were purified by cell sorting and expanded with plate-bound anti-CD3 and soluble anti-CD28 mAbs in the presence of
PHA, IL-2, and IL-7 for two rounds (14 d each). Cell numbers were counted on days 0, 14, and 28, and are shown at 31023. Fold increase: compared
to the starting cell numbers.
Exp., experiment.
NA, not available.
Table II. IFN-g and IL-4 Production by NKT Cells Stimulated 
with Anti-CD3 and Anti-CD28 mAbs
IFN-g IL-4
IL-4/IFN-g
ratio
pg/ml pg/ml
Adult blood NKT Exp. 1 3,321 484 0.15
Exp. 2 3,366 885 0.26
Exp. 3 2,914 268 0.09
Cord blood NKT Exp. 1 1,671 1,069 0.64
Exp. 2 1,889 5,559 2.94
Exp. 3 650 548 0.84
Va24b111 NKT cells were purified by cell sorting, expanded with
plate-bound anti-CD3 and soluble anti-CD28 mAbs in the presence of
PHA, IL-2, and IL-7 for two rounds (14 d each), and restimulated with
immobilized anti-CD3 and soluble anti-CD28 mAbs at 3106 cells per
milliliter for 24 h. IFN-g and IL-4 in the supernatants were measured
by ELISA.
Exp., experiment.
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DC1 preferentially induce Th1 differentiation, CD40L-
activated CD11c2 plasmacytoid cell–derived DC2 prefer-
entially induce Th2 differentiation of naive CD41 T cells
(13). Thus, DC2 were added to the NKT cell cultures to-
gether with PHA, IL-2, and IL-7 at the beginning of the
culture and at the end of 2 wk of culture. After a total of 4
wk of culture, NKT cells were restimulated with anti-CD3
and anti-CD28 mAbs for either 5 (for intracellular cytokine
staining) or 24 h (for cytokine analyses by ELISA). In paral-
lel, the effect of DC1 on neonatal NKT cell differentiation
was analyzed.
Addition of DC2 resulted in a twofold increase in the
percentage of IL-41IFN-g2 NKT2 cells (64%; Fig. 2 A)
compared with the polyclonal stimulation with anti-CD3
and anti-CD28 mAbs (31%; Fig. 1). Only 8 and 1% of the
NKT cells cultured with DC2 became IL-41IFN-g1
NKT0 cells and IL-42IFN-g1 NKT1 cells, respectively
(Fig. 2 A). In contrast, addition of DC1 preferentially in-
duced neonatal NKT cells to become IL-42IFN-g1 NKT1
cells (38%), and to a lesser extent IL-41IFN-g1 NKT0 cells
(26%) and IL-41IFN-g2 NKT2 cells (10%; Fig. 2 A).
Neonatal NKT cells cultured with DC2 produced more
IL-4 (4,900–16,200 pg/ml) and similar amounts of IFN-g
(230–1,450 pg/ml; Fig. 2 B) compared with those stimu-
lated with anti-CD3 and anti-CD28 mAbs (548–5,559 pg/
ml IL-4 and 650–1,889 pg/ml IFN-g; Table I). Neonatal
NKT cells cultured with DC1 produced much more IFN-g
(97,000–222,000 pg/ml) and less IL-4 (1,400–6,900 pg/ml)
than those cultured with DC2 (230–1,450 pg/ml IFN-g
and 4,900–16,200 pg/ml IL-4; Fig. 2 B). These results sug-
gest that DC2 further promote development of neonatal
NKT cells into IL-41IFN-g2 NKT2 cells. In addition, a
large fraction of neonatal NKT cells can be polarized into
IL-42IFN-g1 NKT1 cells by DC1.
Adult NKT Cells Have Limited Plasticity for Polarization In-
duced by DC1 or DC2. Next, we examined whether the
addition of DC2 would induce a large number of IL-
41IFN-g2 NKT2 cells from adult NKT cells, which pro-
Figure 1. Intracellular staining for IL-4 and IFN-g in NKT cells from
adult or cord blood stimulated with anti-CD3 and anti-CD28 mAbs.
Va241Vb111 NKT cells were purified by cell sorting, expanded with
anti-CD3 and anti-CD28 mAbs in the presence of PHA, IL-2, and IL-7
for two rounds (14 d each), and restimulated with immobilized anti-CD3
mAb and soluble anti-CD28 mAb at 106 cells per milliliter ml for 5 h.
Brefeldin A was added at 2.5 h for intracellular cytokine staining. Percent-
ages in each quadrant are indicated on the plots. The data shown are from
one experiment representative of three experiments.
Figure 2. IL-4 and IFN-g production by NKT cells from cord blood
or adult blood cultured with DC1 or DC2. Va241Vb111 NKT cells
were purified by cell sorting, expanded with DC1 or DC2 in the pres-
ence of PHA, IL-2, and IL-7 for two rounds (14 d each), and restimulated
as in Fig. 1. (A) Intracellular staining for IL-4 and IFN-g. Percentages in
each quadrant are indicated on the plots. The data shown are from one
experiment representative of three experiments. (B) ELISA. Data from
three experiments are shown by scattergram.
duce both IL-4 and IFN-g after polyclonal TCR stimula-
tion (Table II, and Fig. 1). Although DC2 induced an in-
crease in the percentage of IL-41IFN-g2 NKT2 cells
(23%; Fig. 2 A) compared with polyclonal TCR stimula-
1225 Kadowaki et al. Brief Definitive Report
tion (8%; Fig. 1), the predominant population of adult
NKT cells cultured with DC2 became IL-41IFN-g1
NKT0 cells (63%; Fig. 2 A). Accordingly, adult NKT cells
cultured with DC2 produced large amounts of IL-4
(2,400–10,700 pg/ml) as well as IFN-g (5,000–46,000 pg/
ml; Fig. 2 B). Similarly, adult NKT cells cultured with
DC1 preferentially developed into IL-41IFN-g1 NKT0
cells (52%) and to a lesser extent into IL-42IFN-g1 NKT1
cells (28%; Fig. 2 A). Accordingly, adult NKT cells cul-
tured with DC1 produced a large amount of IFN-g
(48,000–124,000 pg/ml) and IL-4 (2,600–10,100 pg/ml;
Fig. 2 B). These results indicate that the predominant pop-
ulation of adult NKT cells has an NKT0 phenotype and
poor plasticity for polarization to NKT1 or NKT2 cells.
Discussion
Accumulating findings indicate that IL-4–producing
NKT cells are likely to play an important role in control-
ling various Th1-mediated pathological conditions such as
type 1 diabetes (7) and GVHD (8). Thus, it is important to
understand how the development of IL-4– versus IFN-g–
producing NKT cells is regulated. Furthermore, expanding
the population of IL-4–producing NKT cells may serve to
reduce the activity of these diseases. Here we demonstrated
that the rare human NKT cells isolated from adult or cord
blood have great potential to expand in cultures with IL-2,
IL-7, PHA, anti-CD3, and anti-CD28 mAbs. Although
adult NKT cells displayed an IL-41IFN-g1 NKT0 pheno-
type, a large population of neonatal NKT cells became IL-
41IFN-g2 NKT2 cells in this culture condition. More-
over, neonatal NKT cells could be further polarized into
IL-41IFN-g2 NKT2 cells in cultures with DC2, whereas
adult NKT cells showed poor plasticity for polarization.
These results suggest that newly generated and functionally
immature NKT cells, such as the ones in cord blood rather
than the already primed mature NKT cells, such as the
those in adult blood, may have greater potential to develop
into IL-4–producing NKT2 cells and thus to inhibit Th1-
mediated pathological conditions.
It has been shown that adult but not neonatal NKT cells
have oligoclonally expanded and have obtained primary ef-
fector functions (11). In addition, mouse NKT cell num-
bers increase after birth (1). Here we showed that adult
blood tends to contain more NKT cells than cord blood.
These findings suggest that NKT cells may continue to be
stimulated by self- and/or environmental antigens presented
on CD1d, leading to chronic activation and expansion after
birth. This, together with our finding that adult NKT cells
produce more IFN-g and display less plasticity for polariza-
tion than neonatal NKT cells, suggests that NKT cells may
progressively acquire the bias to produce IFN-g by chronic
stimulation and may thus trigger the onset of autoimmune
diabetes in predisposed individuals at certain ages (6).
It remains to be determined whether neonatal NKT cells
have an intrinsic tendency to differentiate into IL-41IFN-g2
NKT2 cells or if the culture conditions used in this study
selectively expanded the cells that had acquired the ability
to produce this pattern of cytokines. Nevertheless, the clear
differences in cytokine profiles between neonatal and adult
NKT cells cultured in comparable conditions indicate
greater flexibility of neonatal NKT cells in changing their
cytokine profiles as a population level. This property of
neonatal NKT cells may be related to their functional im-
maturity, as demonstrated by the inability to produce IL-4
or IFN-g upon primary stimulation (11), and is reminiscent
of a property of conventional naive CD41 T cells, which
need to be primed to acquire the ability to produce Th1 or
Th2 cytokines.
The invariant Va241 TCR on human NKT cells specif-
ically recognizes CD1d (21). CD40L-activated DC1 ex-
pressed a low level of CD1d as reported (15), and anti-
CD1d mAb diminished IFN-g production by NKT cells
cultured with DC1 (data not shown). However, CD40L-
activated DC2 did not express a detectable level of CD1d,
and anti-CD1d mAb did not diminish IFN-g production
by NKT cells cultured with DC2 (data not shown). Thus,
DC1 stimulate NKT cells through CD1d, whereas DC2
promote NKT2 cell differentiation in a TCR-independent
manner, as DCs modulate functions of B cells (22) and NK
cells (23) independently of the interaction between MHC
class molecules and TCRs. In addition, compared with cul-
ture with anti-CD3 and anti-CD28 mAbs, culture with
DC1 or DC2 overall increased the absolute level of cyto-
kines from NKT cells, except for IFN-g from neonatal NKT
cells cultured with DC2. This enhancement of cytokine pro-
duction is probably due to combined effects of various co-
stimulatory molecules and cytokines derived from DCs.
In summary, this study demonstrates the remarkable ca-
pacity of cord blood NKT cells to preferentially develop
into IL-41IFN-g2 NKT2 cells. Furthermore, the cytokine-
producing capacity of NKT cells can be modulated by the
distinct subsets of DCs, DC1 and DC2. Developing effi-
cient methods to isolate and expand NKT cells, particularly
the IL-41IFN-g2 NKT2 population, may offer the possi-
bility of using them in cell therapies for autoimmune dis-
eases and GVHD.
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